Food Supplements Based on Nettle and Peppermint to Control Signs and Symptoms Induced by Cancer Therapies
The main purpose of this study is to evaluate the impact of food supplements (herbal remedies) on sign and symptoms induced by cancer therapies: Nettle will be administered for improvement of anemia and fatigue; Peppermint will be administered for improvement of nausea. Secondary aims of the trial are to evaluate the impact of these supplements on the quality of life and to evaluate their tolerability profile.
Breast Cancer|Gynecologic Cancer
DIETARY_SUPPLEMENT: Stinging Nettle|DIETARY_SUPPLEMENT: Stinging Nettle|DIETARY_SUPPLEMENT: Peppermint
Anemia, Assessment of hemoglobin levels every 4 weeks., Patients will be followed from date of enrollment for a maximum period of 6 months. Hemoglobin levels monitoring performed for a maximum period of 6 months or until the worsening of anemia (Hb<10 g/dL).|Fatigue, Evaluation of fatigue with questionnaire "Brief Fatigue Inventory" - BFI, completed by the patients at day 1 of every cycle of chemotherapy., Patients will be followed from date of enrollment for a maximum period of 6 months.|Nausea, Evaluation of nausea with questionnaire "Multinational Association of Supportive Care in Cancer" - MAT, completed by the patients at day 2 and day 5 of every cycle of chemotherapy., Patients will be followed from date of enrollment for a maximum period of 6 months.
Quality of life level: questionnaire, Evaluation of quality of life with questionnaire EQ-5D, completed at day 1 of every cycle of chemotherapy by patients enrolled in the three arms., Patients will be followed from date of enrollment for a maximum period of 6 months.|Tolerability of food supplements, Evaluation of tolerability of food supplements through registration of adverse events at each patient visit., Patients will be followed from date of enrollment for a maximum period of 6 months.
The main purpose of this study is to evaluate the impact of food supplements (herbal remedies) on sign and symptoms induced by cancer therapies: Nettle will be administered for improvement of anemia and fatigue; Peppermint will be administered for improvement of nausea. Secondary aims of the trial are to evaluate the impact of these supplements on the quality of life and to evaluate their tolerability profile.